Oral Thin Films Labeled as Novel Drug Delivery System Owing to Several Advantages Help Control Opioid Abuse

The global oral thin films market is foreseen to gain momentum with rising adoption in the pharmaceuticals industry. Oral thin films put a number of advantages on the table. For instance, they offer quick absorption of drugs and high bioavailability. Furthermore, they offer ease of handling and transportation, bypassing of hepatic first pass effect, and fast onset of action. They are also used to help reduce opioid abuse, especially in the U.S.

This could be evident with Redwood Scientific Technologies’ (RSCI) decision to explore the possibility of using oral thin film strips to deliver prescription opioids. Announced in April 2018, this decision is backed by another initiative of using its own barcodes and individual blockchain proprietary techniques to monitor, track, and ensure safety of all levels of opioid-based products.

Transparency Market Research (TMR) envisages the global oral thin films market to rise at a 13.0% CAGR during the completion of the forecast tenure 2018-2026. In 2017, the market earned a US$2.1 bn.

Oral Thin Films Used to Treat Wide Range of Disease Indications

The manufacture of oral thin films involves the usage of polymeric films, which offers important advantages such as enhanced taste masking and systemic absorption. Keeping the drug unbroken until dissolved, oral thin films help prevent acid sensitive drugs to undergo gastrointestinal degradation. Following are other factors that could increase the application of oral thin films in the coming years.

  • Oral thin films find application in the treatment of a broad scope of diseases including nausea, opioid dependence, migraine, schizophrenia, and erectile dysfunction.
  • Tablets are said to be better substituted by sublingual oral thin films as they offer full drug delivery for fast relief.
  • Development of oral thin films in pharmaceuticals dosage form is regarded as an innovation on the part of drug delivery system.

Lower manufacturing cost of oral thin films in comparison with complex drug delivery systems is anticipated to set the tone for valuable growth in the global market. Moreover, there could be high revenue growth expected by the market owing to the introduction of innovative drug delivery systems for current drug portfolios.

Acceptance of Novel Drug Delivery Technologies Strengthens North America

From a geographical perspective, North America is foretold to grab a colossal share of the international oral thin films market because of early adoption and easy access to novel drug delivery technologies. The region is witnessing a shift in trend where oral thin films are being adopted in place of oral tablets.

  • North America could get more attention due to the attractive growth observed in the U.S. Furthermore, increasing prevalence of various diseases is predicted to support the regional growth of the market for oral thin films.
  • The demand for oral thin films in the region could be boosted with product affordability, high purchasing power, and increasing awareness about advanced healthcare technologies used for disease treatment and diagnosis.
  • Not to forget, increase in new drug approvals and research and development and strong presence of leading players of the industry are projected to help the region to stay in a commanding position of the market.

Some of the key companies operating in the international oral thin films market are Aquestive Therapeutics, Inc., Indivior plc, and ZIM Laboratories Limited.


Post a Comment

Note: only a member of this blog may post a comment.

Latest Post

Market Research Reports